Susquehanna International Group
SCMP

Susquehanna International Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Susquehanna International Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-85,500
Closed -$1.01M – 10345
2017
Q3 		$1.01M Buy
85,500
+1,600
+2% +$17.9K ﹤0.01% 5249
2017
Q2 		$881K Sell
83,900
-21,100
-20% -$215K ﹤0.01% 5526
2017
Q1 		$1.16M Buy
105,000
+50,600
+93% +$587K ﹤0.01% 4823
2016
Q4 		$737K Buy
54,400
+8,000
+17% +$112K ﹤0.01% 6167
2016
Q3 		$571K Buy
46,400
+10,800
+30% +$127K ﹤0.01% 5834
2016
Q2 		$391K Buy
35,600
+17,000
+91% +$190K ﹤0.01% 6537
2016
Q1 		$203K Sell
18,600
-28,000
-60% -$354K ﹤0.01% 7946
2015
Q4 		$806K Buy
46,600
+20,400
+78% +$366K ﹤0.01% 5850
2015
Q3 		$521K Sell
26,200
-9,400
-26% -$216K ﹤0.01% 7038
2015
Q2 		$585K Buy
35,600
+13,500
+61% +$234K ﹤0.01% 7300
2015
Q1 		$344K Sell
22,100
-29,700
-57% -$460K ﹤0.01% 7729
2014
Q4 		$740K Buy
+51,800
New +$547K ﹤0.01% 6455

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Susquehanna International Group's SCMP Position: Q1 2018 in Review

Susquehanna International Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 176,051 shares — an estimated $3.16M sold.

Susquehanna International Group first reported a position in SCMP in Q4 2014 and held it in 11 quarters. The position peaked at $4.26M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Susquehanna International Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 176,051 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.16M.
  • Susquehanna International Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
  • Susquehanna International Group's Sucampo Pharmaceuticals, Inc. position peaked at $4.26M in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.